Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Robert F. Kennedy, Jr, will lead the nation’s largest health and human services agency after today’s US Senate vote. Many ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

Nearly 1,300 probationary employees at the CDC -- roughly one-tenth of the agency's workforce -- are being forced out under ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Kennedy, a vicious opponent of vaccines and public health more broadly, is rapidly fulfilling his campaign promise to “give ...

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

Drugmakers — major beneficiaries of NIH-backed university research — have been largely silence on the Trump administration's ...

President Donald Trump is pursuing changes at NIH that would result in ten of millions of dollars in funding cuts for Texas ...

Removing information from the CDC website, as well as other federal health websites, is endangering both patient care and public health, infectious disease experts said Friday.